Hepatitis C Treatment Snapshots: ledipasvir and sofosbuvir co-formulation

Hepatitis C Treatment Snapshots: ledipasvir and sofosbuvir co-formulation

For a simplified snapshot from TREAT Asia/amfAR on ledipasvir and sofosbuvir co-formulation for the treatment of hepatitis C, please click here.

/ News

Jagādhri Share the Post

http://flooring.jamescaine.com/laminate/ Related Posts

Four Indian generic companies take sub license from MPP on daclatasvir
Community group taking actions to enable greater access for generic HCV treatment
Asia-Pacific Aids Groups Express Deep Dismay At Conclusion Of Secretly Negotiated Trans-Pacific Partnership Agreement That Threatens Future Access To Affordable Generic Medicines And Sustainable Development Goals
BMS’ patent bid for Hep C treatment Daclatasvir Challenged
Updated Patent Situation on Key Products for Hepatitis C Treatment in Asia – August 2015
Know the interactions between HIV and Hep C medicines
Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis C
Patent Situation of The Key Product For Treatment of Hepatitis C: SOFOSBUVIR – WHO working paper, updated 2015